Industry: Pharmaceuticals Region: Europe Transaction Price: US $1million Method of transaction: Equity investment
The underlying situation
The target company is a European pharmaceutical R&D and manufacturer. It is an international, family-owned company that develops the most modern medicines with its expertise and long experience.
The underlying business
The company can prepare a variety of medicines, including a variety of sprays, knead granules, tablets, film tablets, suppositories, ointments and gels, among others. The company also has a wide range of proprietary technologies in the manufacture of herbal preparations.
Based on the international market, the company is currently active in dozens of countries/regions, with Western and Eastern Europe as its key markets.
The underlying product
The company's drugs are mainly used in the following areas:
OTC drugs:
• cough
• Adult sleep disorders
Prescription drugs:
• Relieve moderate and ultra-high pain levels
• Treat anxiety, excitement and tension
• Major depression in adults
• Chronic migraines
• Mild withdrawal symptoms caused by addiction
• Sleep disorders
Cooperation intention
The company is interested in selling. Please contact us if you are interested.